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ORGANOIDS
Synthetic scaffolds help airway
cells reach maturity
Transplanting bioengineered human lung organoids into mice could lead
to a humanized model for pre-clinical studies of lung disease.
MARKO Z NIKOLIC´ AND EMMA L RAWLINS
T
he human airways bring air into and out
of the lungs, and the epithelium that
lines these airways uses a combination of
mucus and hair-like structures called cilia to clear
inhaled particles and microorganisms from the
lungs. For decades cell biologists have been
able to make mature airway epithelia in vitro by
taking airway cells from patients and cadavers
and growing them in culture. These epithelia
have been used for a range of applications, from
fundamental cell biology and cancer genetics to
clinical diagnosis and pharmacological testing
(discussed in Fulcher et al., 2005). In recent
years researchers have been trying to use human
pluripotent stem cells – cells that can differenti-
ate to become any of the types of cells that are
found in the body – to make mature airway epi-
thelia. However, if such epithelia are available
from real people, potentially with a complete
medical history, why is there any interest in using
pluripotent stem cells to make them?
The answer is two-fold. First, the adult epithe-
lia grown in culture suffer from various limita-
tions: they are highly variable, they contain only
a limited range of cell types, and it is not possi-
ble to introduce targeted genetic mutations in
them, although numerous labs are working to
solve these issues (Mou et al., 2016;
Butler et al., 2016). Second, the use of pluripo-
tent stem cells to make mature airway epithelia
has the attraction of allowing researchers to
study the progressive development of a disease
over time. In addition, the use of pluripotent
stem cell lines will make it possible to introduce
a specific genetic alteration and study its effect
by comparing these cell lines to otherwise
genetically identical control cells. Reproducible
growth of epithelia with these features has the
potential to improve disease modeling, to facili-
tate drug discovery across a range of lung dis-
eases, and to provide a limitless supply of cells
for toxicology testing, or even for regenerative
medicine. However, while there have been
numerous reports of methods for producing
mature airway epithelia from pluripotent stem
cells, the cells in these epithelia have tended to
resemble embryonic and neonatal cells rather
than mature adult cells.
The airways and lungs are derived from a
region in the developing embryo called the
anterior foregut endoderm. A typical method for
making mature epithelia from stem cells involves
starting with pluripotent stem cells and coaxing
them to become endoderm cells, then anterior
foregut endoderm cells, then lung progenitor
cells (which can become any type of lung cell)
and, finally, various types of airway epithelial
cells. One recent innovation involved the growth
of three-dimensional structures called human
lung organoids by a group at the University of
Michigan (Dye et al., 2015) and another group
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at Kyoto Univerisity and Osaka University
(Konishu et al., 2016). These organoids con-
tained many of the cell types that are found in
mature airway epithelia but, notably, they did
not contain mature goblet cells (the cells that
produce mucus) or a number of other secretory
cells (Figure 1A). Now, building on their previ-
ous work, Jason Spence of the University of
Michigan and co-workers – including Briana Dye
as first author – report that these shortcomings
can be overcome by using a combination of syn-
thetic "scaffolds" and in vivo growth in mice
(Dye et al., 2016).
It has become a standard technique to
implant immature organoids (or cells derived
from pluripotent stem cells) into well-vascular-
ized sites in mice whose immune system has
been compromised. The growth of the cells in
this in vivo environment, typically in the kidney
capsule or in fatty tissue adjacent to the stomach
or epididymis, helps them to mature properly,
presumably due to the physiological levels of
nutrients, oxygen and circulating factors. Dye
et al. started by taking human lung organoids
that had been grown in a basement membrane
substrate (Matrigel) and implanting them directly
into the mice. Although human epithelia were
recovered from these initial transplants, they
rarely contained lung cells.
In an attempt to solve this problem Dye et al.
decided to first culture the organoids on syn-
thetic scaffolds made of a polymer called Poly
(lactide-co-glycolide), which is used in medical
devices and for culturing pancreatic cells
(Yap et al., 2013). Given the size of the scaf-
folds, the only suitable transplantation site was
the fat pad adjacent to the epididymis (which is
near the testicles in male mice). When the scaf-
folds were retrieved from the mice, typically fol-
lowing 8–15 weeks of growth in vivo, the
Figure 1. In vitro and in vivo differentiation of lung organoids. Human pluripotent stem cells (not shown) can be
differentiated to become three-dimensional bunches of cells that are fated to anterior foregut endoderm cells.
When Dye et al. plated such foregut spheroids (green circles) into a substrate (Matrigel) and cultured them in vitro
for approximately 8 weeks (A), they observed levels of differentiation similar to embryonic human lungs, including
ciliated cells (light green), basal cells (blue) and rare secretory cells (not shown). However, when Dye et al. seeded
foregut spheroids onto synthetic scaffolds and cultured them for approximately 1 week in vitro, and then
transplanted them into the epididymal fat pad of immunocompromised mice for 8–15 weeks (B), they observed
greater levels of differentiation, including ciliated cells (light green), basal cells (blue), goblet cells (red) and
secretory cells (magenta) lining the surfaces of tubular airway-like structures. The organoids also appeared to be
connected to the vasculature of the mice.
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organoids had frequently grown into tubes that
resembled the adult airway and, moreover, they
contained a wider range of mature cell types
than had been produced before (Figure 1B).
Importantly, this latter finding was validated by
detailed comparison to human fetal and adult
airways.
The in vivo system developed by Dye, Spence
and co-workers appears to be reproducible
across multiple pluripotent cell lines and could
be used to develop improved models of adult
lung diseases and for pre-clinical drug testing.
And if we can learn more about the mechanisms
that underlie the maturation process, it might be
possible to produce mature epithelia in vitro for
high-throughput (drug discovery-type) experi-
ments. It will also be important to assess
whether mature alveoli (the lung cells that are
involved in the exchange of oxygen and carbon
dioxide) can be generated from pluripotent
stem cells through similar in vivo transplantation
approaches. Further study is also needed to
assess how different types of scaffolds affect the
maturation of cells in vivo.
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